Chongqing Genrix Biopharmaceutical Co Ltd
Company Profile
Business description
Chongqing Genrix Biopharmaceutical Co Ltd is engaged in the research & development, production and sales of antibody drugs. The company has a total of more than ten products under research covering three major therapeutic areas. The progress of core products is leading, and some product pipelines are as follows; autoimmune disease, infectious disease, and tumor. Its product Xeligekimab injection (Xeligekimab) is a recombinant fully human anti-IL-17A monoclonal antibody independently developed by the company, which has been accepted by the National Medical Products Administration (NMPA) for new drug marketing applications.
Contact
No. 699, Maliu Avenue
Area A, Building 2
International Bio City
Banan
Chongqing 401338
CHNT: +86 2361758666
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
547
Stocks News & Analysis
stocks
Going into earnings, Is Apple stock a buy, a sell, or fairly valued?
stocks
One of the hottest shares on the ASX reports strong growth
stocks
Diverging value in Australia's real estate sector
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,165.50 | 71.20 | 0.88% |
| CAC 40 | 7,427.02 | 86.71 | -1.15% |
| DAX 40 | 18,298.72 | 88.74 | -0.48% |
| Dow JONES (US) | 39,935.07 | 81.20 | 0.20% |
| FTSE 100 | 8,186.35 | 32.66 | 0.40% |
| HKSE | 17,033.91 | 28.94 | 0.17% |
| NASDAQ | 17,181.72 | 160.69 | -0.93% |
| Nikkei 225 | 37,973.16 | 103.65 | 0.27% |
| NZX 50 Index | 12,369.83 | 26.44 | -0.21% |
| S&P 500 | 5,399.22 | 27.91 | -0.51% |
| S&P/ASX 200 | 7,932.70 | 71.50 | 0.91% |
| SSE Composite Index | 2,881.23 | 5.51 | -0.19% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Bellevue Gold Ltd BGL | 1.42 | 0.41 | -22.54% |
| Argosy Minerals Ltd AGY | 0.05 | 0.02 | 47.06% |
| Pilbara Minerals Ltd PLS | 2.98 | 0.11 | 3.66% |
| Droneshield Ltd DRO | 1.40 | 0.09 | -5.87% |
| Sayona Mining Ltd SYA | 0.03 | 0.00 | 1.61% |
| Core Lithium Ltd CXO | 0.10 | 0.01 | 6.59% |
| Red 5 Ltd RED | 0.38 | 0.02 | -5.06% |
| Zip Co Ltd ZIP | 1.78 | 0.03 | -1.66% |
| Liontown Resources Ltd LTR | 0.95 | 0.03 | 3.28% |
| Peninsula Energy Ltd PEN | 0.11 | 0.01 | 7.50% |